🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Shadfar Bahri

University of California, Los Angeles

ORCID: 0000-0002-2622-389X
MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Safety of PSMA-Targeted Molecular Radioligand Therapy with 177Lu-PSMA-617: Results from the Prospective Multicenter Phase 2 Trial RESIST-PC (NCT03042312)”.

Safety of PSMA-Targeted Molecular Radioligand Therapy with 177Lu-PSMA-617: Results from the Prospective Multicenter Phase 2 Trial RESIST-PC (NCT03042312)

Journal of Nuclear Medicine(2021)10.2967/jnumed.121.262543
N/A
0DataRank · unranked
37 citations

Johannes Czernin, Pan Thin, J Gartmann, Kathleen Nguyen, Wesley R. Armstrong +14 more

Differentiating IDH status in human gliomas using machine learning and multiparametric MR/PET

Cancer Imaging(2021)10.1186/s40644-021-00396-5
N/A
0DataRank · unranked
19 citations

Akifumi Hagiwara, Hiroyuki Uetani, Shadfar Bahri, Catalina Raymond, Albert Lai +7 more

Worse Prognosis for IDH Wild-Type Diffuse Gliomas With Larger Residual Biological Tumor Burden

Research Square(2021)10.21203/rs.3.rs-148651/v1
N/A
0DataRank · unranked
1 citations

Hiroyuki Uetani, Akifumi Hagiwara, Shadfar Bahri, Catalina Raymond, Albert Lai +7 more

Preferential Tumor Localization in Relation to 18F-FDOPA Uptake for Lower-Grade Gliomas

Research Square(2021)10.21203/rs.3.rs-186583/v1
N/A
0DataRank · unranked
0 citations

Hiroyuki Uetani, Akifumi Hagiwara, Jingwen Yao, Talia C. Oughourlian, Issei Ueda +10 more